Rchr
J-GLOBAL ID：201401018268521369
Update date: Oct. 08, 2024
Nakagawa Syunsaku
ナカガワ シュンサク | Nakagawa Syunsaku
Affiliation and department：
Job title：
Associate Professor
Research field (1)：
Clinical pharmacy
Research keywords (1)：
Drug-induced nephropathy, Pharmacoepidemiology, Antibiotics, Proton pump inhibitors
Research theme for competitive and other funds (11)：
- 2023 - 2027 Analysis of biotransformation in therapeutic antibody
- 2021 - 2024 Elucidation of the clinical features and the pathogenic mechanisms of drug-induced kidney injury
- 2019 - 2023 Basic and clinical analysis of anti-drug antibody against therapeutic antibody
- 2017 - 2023 症状-バイオマーカー-薬理プロファイルから考える新たなせん妄薬物療法に関する検討
- 2018 - 2021 Development of therapeutic strategy for drug-induced renal fibrosis
- 2017 - 2020 Effect of renal dysfunction on the pharmacokinetics and pharmacodynamics of fluorouracil and its derivatives
- 2016 - 2018 Mechanisms underlying drug-induced tubulointerstitial nephritis
- 2015 - 2018 Molecular mechanism underling improvement of oxaliplatin-induced neuropathy by duloxetine
- 2015 - 2017 Different etiologic mechanisms underlying HFS depending on the classes of anti-cancer agents
- 2014 - 2016 Roles of anti-inflammatory system after drug-induced kidney injury
- 2012 - 2015 Individualized L-dopa therapy in patients with Parkinson's disease
Show all
Papers (107)：
-
Mari Yokoi, Atsushi Yonezawa, Daiki Hira, Tomohiro Handa, Kiminobu Tanizawa, Shunsaku Nakagawa, Masahiro Tsuda, Yasuaki Ikemi, Ryo Itotani, Hironori Yoshida, et al. Subjective symptoms are triggers for the detection of immune checkpoint inhibitor-induced interstitial lung disease and associate with disease severity: a single-center retrospective study. Journal of Pharmaceutical Health Care and Sciences. 2024. 10. 1
-
Ren Takahashi, Kotaro Itohara, Shunsaku Nakagawa, Yoshiki Katada, Mitsuhiro Sugimoto, Keisuke Umemura, Katsuyuki Matsumura, Daiki Hira, Masahiro Tsuda, Yurie Katsube, et al. Model-Informed Dosing Optimization of Tacrolimus for Concomitant Administration with Itraconazole to Japanese Lung Transplant Recipients. Therapeutic drug monitoring. 2024
-
Chinami Yamawaki, Shunsaku Nakagawa, Keiko Ikuta, Yurie Katsube, Natsuki Imayoshi, Yuki Shigetsura, Daiki Hira, Shinya Yamamoto, Takeshi Matsubara, Motoko Yanagita, et al. Association between Proton Pump Inhibitors, Immune Checkpoint Inhibitors, and Acute Kidney Injury: A Nested Case-Control Study. Kidney360. 2024
-
Hanako Naganawa, Yoshiki Katada, Shunsaku Nakagawa, Keisuke Umemura, Hiroki Ishimura, Moto Kajiwara, Hiroki Endo, Mitsuhiro Sugimoto, Yurie Katsube, Kinuka Kotani, et al. Influence of ensitrelvir or nirmatrelvir/ritonavir on tacrolimus clearance in kidney transplant recipients: a single-center case series. Journal of pharmaceutical health care and sciences. 2024. 10. 1. 37-37
-
Yoshiki Katada, Keisuke Umemura, Shunsaku Nakagawa, Yurie Katsube, Masahiro Tsuda, Satona Tanaka, Hiroshi Date, Miki Nagao, Tomohiro Terada. A case of successful contribution of therapeutic drug monitoring of valganciclovir as the prophylaxis against cytomegalovirus infection in a lung transplant recipient. Journal of pharmaceutical health care and sciences. 2024. 10. 1. 28-28
ｍore...
MISC (66)：
-
勝部友理恵, 片田佳希, 片田佳希, 梅村圭祐, 卜部裕月, 平大樹, 津田真弘, 津田真弘, 中川俊作, 大角明宏, et al. 肺移植後におけるバルガンシクロビル経口投与時の血中ガンシクロビルトラフ値と予防効果の後方視的調査. 日本臨床薬理学会学術総会抄録集(Web). 2023. 44th
-
山脇千波, 中川俊作, 幾田慧子, 今吉菜月, 勝部友理恵, 平大樹, 山本伸也, 松原雄, 柳田素子, 寺田智祐. プロトンポンプ阻害薬及び免疫チェックポイント阻害薬の使用と急性腎障害発症との関連性に関する観察研究. 医療薬学フォーラム講演要旨集. 2023. 31st
-
歯科口腔外科における経口抗菌薬適正化の取り組みとその効果. 2020. 35th. O39-2
-
髙橋悠, 片田佳希, 中川俊作, 杉本充弘, 吉田優子, 木全柾典, 糸原光太郎, 北田徳昭, 深津祥央, 米澤淳, et al. Liposomal amphotericin Bによる腎機能障害発現に関連する因子の探索. 日本医療薬学会年会講演要旨集. 2019. 29th
-
梅山遥, 北田徳昭, 片田佳希, 櫻井香織, 野口葉子, 石橋直哉, 家永嘉子, 池見泰明, 中川俊作, 今井哲司, et al. 肺移植後造血器腫瘍患者における多剤併用がん化学療法でボリコナゾールとの相互作用を回避した一例. 医療薬学フォーラム講演要旨集. 2019. 27th. 120
ｍore...
Return to Previous Page
